Lupus Trials News

The best and brightest are working toward finding better treatments and ultimately a cure for lupus. Read about how the most important influencers in the lupus community are effecting lupus research, along with other issues that matter most to you.

Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA

December 10, 2019 The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...

Read More

Lupus Research Alliance Applauds Phase III Trial Results for Potential Lupus Nephritis Treatment

December 4, 2019 The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase III trial results for...

Read More

Positive Study Results in Potential Treatment for Cutaneous and Systemic Lupus

December 3, 2019 The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the...

Read More

Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments

November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...

Read More

Two Lupus Therapeutics Studies Report Positive Results at 2019 ACR/ARP Annual Meeting

November 12, 2019 Two positive clinical studies presented at the 2019 ACR/ARP Annual Meeting were conducted through the Lupus Clinical...

Read More

Potential Lupus Nephritis Treatment Works Well with Mycophenolate Acid

November 8, 2019 Aurinia Pharmaceuticals announced results from a study showing that their investigational drug voclosporin did not significantly impact...

Read More

Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting

NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the Phase...

Read More

Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis

NEW YORK, Nov. 10, 2019 /PRNewswire/ — The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by Genentech...

Read More

LRA Applauds Exciting Lupus Research Being Presented at 2019 ACR/ARP Annual Meeting

Includes 16 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from two...

Read More

New Studies Suggest AVISE Lupus Test Improves Diagnosis of Disease

October 28, 2019 Because lupus is hard to diagnose, many patients don’t get the treatments they need, while others get...

Read More

Epilepsy in People with Lupus

October 17, 2019 A new study published in the European Journal of Neurology showed that epilepsy is significantly more common...

Read More

High Levels of Interferon-Alpha Identifies Lupus Patients At Risk for Relapse

October 7, 2019 A new study published in Annals of the Rheumatic Diseases found that among people with lupus, high...

Read More

LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch

October 1, 2019 The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...

Read More

Nearly One-third of People with Lupus Treat Their Pain with Opioids

September 26, 2019 In a newly published Michigan study, nearly 1 in 3 adults with systemic lupus erythematosus used prescription...

Read More

Lupus Study Showed Vitamin D Did Not Improve Bone Health

September 19, 2019 A small clinical trial published in Lupus Science & Medicine found that taking vitamin D supplements did...

Read More

FDA Expedites Existing Drug Gazyva for Lupus Nephritis

September 18, 2019 The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...

Read More

MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial

NEW YORK, NY. August 29 — The Lupus Research Alliance is excited to share the good news that a potential...

Read More

New Study Shows Benlysta Alters B Cells in People with Lupus

August 21, 2019 Newly published research found that belimumab (Benlysta®) effectively reduced the number of B cells, a type of...

Read More

New Study Shows Active Epstein-Barr Virus Increases Chance for Lupus in At-Risk People

August 13, 2019 New research results showed that active Epstein-Barr virus increases the risk for lupus among relatives of people...

Read More

PALS Clinical Trial Program Opens at Five Universities

August 8, 2019 In five pilot cities, people with lupus who are thinking about taking part in a clinical trial...

Read More

Lupus Expert Dr. Richard Furie Addresses Clinical Trials

June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...

Positive Early Results for BIIB059 as New Treatment Strategy

March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...

People with Lupus at Higher Risk for Bone Fractures, Study Shows

February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...

Physical Fitness Associated with Health-related Quality of Life, Study Shows

February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...

Study Shows Kidney Transplant Improves Lupus Nephritis Survival

A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....

Study shows: Stress, Depression and Pain are Major Contributors to Lupus Fatigue

An observational study published in Lupus of people with lupus found that of six factors,  stress, depression and pain contributed most to...

Existing Asthma Medication Shows Effectiveness for Lupus

A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...

New Trial Begins to Test Investigational Cenerimod to Treat Lupus

Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA)  announced that the first patient has been enrolled into a multiple-dose study...

Poor Dental Care Associated with Lupus

A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...

Association Between Lupus and Cancer

A new analysis published in Arthritis Research & Therapy found that SLE is associated with increased risk of 16 cancers and decreased...